Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Diabetes Mellitus, Type 2 / Drug Therapy"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"330 - Economics"
Search alternatives
:
type »
types
Showing
1
-
20
of
25
Search:
'"Diabetes Mellitus, Type 2 / Drug Therapy"'
,
query time: 0.29s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Pharmacoeconomic review report: Dapagliflozin (Forxiga)
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
2
Pharmacoeconomic review report: Dapagliflozin (Forxiga)
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
3
Pharmacoeconomic review report: Empagliflozin and Metformin fixed-dose combination (Synjardy)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
4
Pharmacoeconomic review report: Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
5
Pharmacoeconomic review report: Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Insulin glargine and lixisenatide (Soliqua -- Sanofi-Aventis Canada Inc.) : indication : adjunct to diet and exercise to improv...
Published 2019
CADTH
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
7
CADTH Canadian Drug Expert Committee recommendation: Lixisenatide (Adlyxine -- Sanofi-Aventis Canada inc.) : indication : diabetes mellitus, type 2
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
8
Pharmacoeconomic review report: Empagliflozin (Jardiance)
Published 2015
CADTH
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
9
Pharmacoeconomic review report: Empagliflozin (Jardiance)
Published 2015
CADTH
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
10
Pharmacoeconomic review report: Insulin glargine + lixisenatide (Soliqua) (Sanofi-Aventis) : indication : adjunct to diet and exercise to improve glycemic control in adults with ty...
Published 2019
CADTH
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
11
Pharmacoeconomic review report: Insulin glargine + lixisenatide (Soliqua) (Sanofi-Aventis) : indication : adjunct to diet and exercise to improve glycemic control in adults with ty...
Published 2019
CADTH
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Insulin degludec (Tresiba -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, types I and II.
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
13
Second- and third-line pharmacotherapy for type 2 diabetes : update of CADTH 2010 reviews :project protocol
Published 2012
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
14
Third-line pharmacotherapy for type 2 diabetes : update
Published 2013
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
15
Second- and third-line pharmacotherapy for type 2 diabetes : update of CADTH 2010 reviews :project protocol
Published 2012
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
16
Third-line pharmacotherapy for type 2 diabetes : update
Published 2013
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
17
CADTH Canadian Drug Expert Committee recommendation: Semaglutide (Ozempic -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, type 2 to improve glycemic control
Published 2019
CADTH
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
18
CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
19
CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
Read Now
20
Pharmacoeconomic review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus
Published 2019
CADTH
Subjects:
“
...
Diabetes
Mellitus
,
Type
2
/
drug
therapy
...
”
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 330 - Economics
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
10
Language
English
25
Collection
National Center for Biotechnology Information
25
Author
Canadian Agency for Drugs and Technologies in Health
20
CADTH Canadian Drug Expert Committee
10
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&lookfor=%22Diabetes+Mellitus%2C+Type+2+%2F+Drug+Therapy%22&type=Subject
Send by Email
×
Loading...